Skip to main content
editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
American Journal of Pharmacy and Health Research

American Journal of Pharmacy and Health Research

Published

INVESTIGATING CLINICAL OUTCOMES OF ALPHA-BLOCKER MONOTHERAPY COMPARED TO COMBINED 5-ARI PROTOCOLS IN THE CONTEXT OF BENIGN PROSTATIC HYPERPLASIA

Published in May 2026 Issue 05 (Vol. 14, Issue 5, 2026)

INVESTIGATING CLINICAL OUTCOMES OF ALPHA-BLOCKER MONOTHERAPY COMPARED TO COMBINED 5-ARI PROTOCOLS IN THE CONTEXT OF BENIGN PROSTATIC HYPERPLASIA - Issue cover

Abstract

Benign prostatic hyperplasia (BPH) is a common condition in elderly men characterized by prostate enlargement, resulting in lower urinary tract symptoms (LUTS) that significantly impact quality of life. Pharmacological management includes alpha-blockers and 5-alpha reductase inhibitors (5-ARIs). To compare the clinical outcomes of alpha-blocker monotherapy with combination therapy in patients with BPH. A 6-month prospective comparative study was conducted in 100 patients with moderate to severe BPH. Patients were treated with either alpha-blocker monotherapy or combination therapy (alpha-blocker with 5-ARI). Clinical outcomes were evaluated using the International Prostate Symptom Score (IPSS) at baseline and after 3 months. Statistical analysis was performed with significance set at p<0.05. Both treatment groups showed improvement in LUTS. However, combination therapy resulted in a greater reduction in IPSS scores and improved clinical response compared to monotherapy, particularly in patients with more severe symptoms. Combination therapy provides superior clinical outcomes and may offer better long-term disease control, while monotherapy remains effective for rapid symptomatic relief. KEYWORDS: Benign prostatic hyperplasia, alpha-blockers, 5-alpha reductase inhibitors, combination therapy, IPSS score, prostate volume.

Citations & discovery

Explore citations to this article and find it in scholarly databases.

Crossref
…
Citations
View record
Europe PMC
…
DOI matches
View results
Google Scholar

Checking citation sources…

Citation counts reflect each source's coverage. Europe PMC shows DOI search matches, including mentions in references. Article lists may be incomplete. Google Scholar opens a separate search.

Authors (7)

G. VANI

QIS College of Pharmacy, Venga...

View all publications →

SK.ABDUL SALEEM

Professor, and HOD Department ...

View all publications →

G. JAGADAMBA LAKSHMI SARASWATHI

Scholars, Pharm D, QIS College...

View all publications →

K. ANAND KUMAR

Scholars, Pharm D, QIS College...

View all publications →

M. DEVID RAJU

Scholars, Pharm D, QIS College...

View all publications →

G. KIRAN KUMAR

Associate Professor, M.S, M.Ch...

View all publications →

M. KISHORE BABU

Principal and Professor, QIS C...

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.7 MB
Format: PDF

Summarise this paper with AI:

Article Information

AJPHR5140002

AJPHR-01-000913

27-39

2026-05-19

JATS XML

Article Impact

Views:2,688
Downloads:1,560
scite_
PlumX Metrics Badge

How to Cite

VANI, G., SALEEM, S., JAGADAMBA LAKSHMI SARASWATHI, G., ANAND KUMAR, K., DEVID RAJU, M., KIRAN KUMAR, G., & KISHORE BABU, M. (2026). INVESTIGATING CLINICAL OUTCOMES OF ALPHA-BLOCKER MONOTHERAPY COMPARED TO COMBINED 5-ARI PROTOCOLS IN THE CONTEXT OF BENIGN PROSTATIC HYPERPLASIA. American Journal of Pharmacy and Health Research, 14(5), 27-39. https://doi.org/10.5281/zenodo.20285803

Article Actions

Whatsapp